Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.87)
# 672
Out of 5,115 analysts
336
Total ratings
41.48%
Success rate
13.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $49.96 | +60.13% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $71.71 | +4.59% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $82.67 | -21.37% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $24.51 | -42.88% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $13.33 | +650.19% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $34.23 | +31.46% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $17.50 | +328.57% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $30.82 | -2.66% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $14.48 | +203.87% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $20.34 | -50.84% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $24.06 | -58.43% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.15 | +128.14% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.09 | +1,663.05% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $15.11 | -0.73% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.16 | +331.03% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.01 | -37.58% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $5.69 | -12.13% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $7.41 | +102.43% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $17.66 | +154.81% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.99 | +50.75% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.83 | +485.65% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.54 | +354.55% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.68 | -47.18% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.90 | +5.26% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.21 | +643.80% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.09 | +194.70% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $1,723,250 | $0.82 | +211,104,885.91% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.38 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $49.96
Upside: +60.13%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $71.71
Upside: +4.59%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $82.67
Upside: -21.37%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $24.51
Upside: -42.88%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $13.33
Upside: +650.19%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $34.23
Upside: +31.46%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $17.50
Upside: +328.57%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $30.82
Upside: -2.66%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $14.48
Upside: +203.87%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $20.34
Upside: -50.84%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $24.06
Upside: -58.43%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $13.15
Upside: +128.14%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $7.09
Upside: +1,663.05%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $15.11
Upside: -0.73%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.01
Upside: -37.58%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $5.69
Upside: -12.13%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $7.41
Upside: +102.43%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $17.66
Upside: +154.81%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $1.99
Upside: +50.75%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.83
Upside: +485.65%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.54
Upside: +354.55%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.68
Upside: -47.18%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.90
Upside: +5.26%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.21
Upside: +643.80%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.09
Upside: +194.70%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $1,723,250
Current: $0.82
Upside: +211,104,885.91%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.38
Upside: -